Skip to content

Efficacy of Peripheral Magnetic Stimulation Compare to Dry Needling in Myofascial Pain Syndrome

Efficacy of Peripheral Magnetic Stimulation Compare to Dry Needling in Patient With Upper Trapezius Myofascial Pain Syndrome

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05320601
Enrollment
32
Registered
2022-04-11
Start date
2022-04-11
Completion date
2022-07-01
Last updated
2022-07-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myofascial Pain Syndrome

Brief summary

Compare efficiency between repetitive peripheral magnetic stimulation and dry needling in patient with upper trapezius myofascial pain syndrome.

Interventions

Repetitive Peripheral Magnetic Stimulation at trigger point of upper trapezius muscle

PROCEDUREDry needling

Dry needling at trigger point of upper trapezius muscle

Sponsors

Mahidol University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
20 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* Patients with myofascial pain syndrome at unilateral upper trapezius muscle and had pain score (Visual analog scale) at least 4

Exclusion criteria

* Patients with signs and/or symptoms of neurological deficit * Patients with history of cervical hernia, cervical radiculopathy, cervical myelopathy, fibromyalgia, whiplash spondylosis and cervical spinal stenosis. * Patients who received physical therapy/injection/surgery at neck or pain area in last 6 months. * Patients with abnormal coagulopathy and/or currently use anticoagulant medicine. * Patients with cardiac device. * Patients with history of aneurysm clip procedure, stent-coils procedure or cochlear implant surgery. * Pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Change of Visual analog scaleChange from baseline Visual analog scale at immediately after intervention, Change from Baseline visual analog scale at 1 week and Change from baseline Visual analog scale at 4 weeksPain measurement Score from 0-10, 0 means no pain and 10 means maximum pain. Higher scores mean worse outcome.

Secondary

MeasureTime frameDescription
Neck disability indexChange from baseline Neck disability index at immediately after intervention, Change from Baseline Neck disability index at 1 week and Change from baseline Neck disability index at 4 weeksDisability secondary to neck pain Score from 0-50, 0 means no disability and 50 means complete disability. Higher scores mean worse outcome.

Other

MeasureTime frameDescription
Pain pressure thresholdChange from baseline Pain pressure threshold at immediately after intervention, Change from Baseline Pain pressure threshold at 1 week and Change from baseline Pain pressure threshold at 4 weeksThe minimum pressure that induces pain in trigger point. Higher scores mean better outcome.

Countries

Thailand

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026